Cargando…

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US

OBJECTIVE: We identified potential geographic “hotspots” for drug-injecting transmission of HIV and hepatitis C virus (HCV) among persons who inject drugs (PWID) in New York City. The HIV epidemic among PWID is currently in an “end of the epidemic” stage, while HCV is in a continuing, high prevalenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Des Jarlais, D. C., Cooper, H. L. F., Arasteh, K., Feelemyer, J., McKnight, C., Ross, Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875800/ https://www.ncbi.nlm.nih.gov/pubmed/29596464 http://dx.doi.org/10.1371/journal.pone.0194799

Ejemplares similares

Geographic distribution of risk (“Hotspots”) for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history
por: Des Jarlais, D.C., et al.
Publicado: (2019)

Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City?
por: Des Jarlais, Don, et al.
Publicado: (2015)

HSV-2 Co-Infection as a Driver of HIV Transmission among Heterosexual Non-Injecting Drug Users in New York City
por: Des Jarlais, Don C., et al.
Publicado: (2014)

Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: Prevalence, risk factors
por: Jarlais, Don Des, et al.
Publicado: (2023)

Modeling HIV transmission among persons who inject drugs (PWID) at the “End of the HIV Epidemic” and during the COVID-19 pandemic
por: Jarlais, Don Des, et al.
Publicado: (2022)

COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City
por: Des Jarlais, Don C., et al.
Publicado: (2023)

Field Testing the “Avoid the Needle” Intervention for Persons at Risk for Transitioning to Injecting Drug Use in Tallinn, Estonia and New York City, USA
por: Jarlais, Don C Des, et al.
Publicado: (2023)

Transitions from Injection-Drug-Use-Concentrated to Self-Sustaining Heterosexual HIV Epidemics: Patterns in the International Data
por: Des Jarlais, Don C., et al.
Publicado: (2012)

Increasing HIV prevention and care for injecting drug users
por: Jarlais, Don C Des, et al.
Publicado: (2010)

A Multistage Process Model of How a Person Who Currently Injects Drugs Comes to Assist Persons Who Do not Inject with Their First Injections
por: Des Jarlais, Don C., et al.
Publicado: (2021)

HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: a scoping review
por: Uusküla, Anneli, et al.
Publicado: (2023)

A qualitative study of persons who inject drugs but who have never helped others with first injections: how their views on helping contrast with the views of persons who have helped with first injections, and implications for interventions
por: Barnes, David M., et al.
Publicado: (2018)

Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention
por: Eckhardt, Benjamin, et al.
Publicado: (2017)

HIV control programs reduce HIV incidence but not HCV incidence among people who inject drugs in HaiPhong, Vietnam
por: Molès, Jean-Pierre, et al.
Publicado: (2020)

30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs
por: Des Jarlais, D. C., et al.
Publicado: (2013)

Gender Differences in HIV, HCV risk and Prevention Needs Among People who Inject drug in Vietnam
por: Giang, Hoang Thi, et al.
Publicado: (2022)

High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review
por: Des Jarlais, Don C, et al.
Publicado: (2013)

Long-Term Persistence of Mitochondrial DNA Instability among HCV-Cured People Who Inject Drugs
por: Durand, Mélusine, et al.
Publicado: (2022)

Respondent-Driven Sampling in a Study of Drug Users in New York City: Notes from the Field
por: McKnight, Courtney, et al.
Publicado: (2006)

Prescription opioid misuse and its relation to injection drug use and hepatitis C virus infection: protocol for a systematic review and meta-analysis
por: Jordan, Ashly E, et al.
Publicado: (2014)

“Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID‐19 in Hai Phong, Vietnam”
por: Giang, Hoang Thi, et al.
Publicado: (2022)

Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II
por: Des Jarlais, Don C, et al.
Publicado: (2006)

Using large-scale respondent driven sampling to monitor the end of an HIV epidemic among persons who inject drugs in Hai Phong, Viet Nam
por: Des Jarlais, Don C., et al.
Publicado: (2021)

Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam–hepatitis C)
por: Rapoud, Delphine, et al.
Publicado: (2020)

Is your syringe services program cost-saving to society? A methodological case study
por: Des Jarlais, Don C., et al.
Publicado: (2021)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016
por: Campbell, Cecily A., et al.
Publicado: (2017)

Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study
por: Uusküla, Anneli, et al.
Publicado: (2018)

Alarming Tuberculosis Rate Among People Who Inject Drugs in Vietnam
por: Nagot, Nicolas, et al.
Publicado: (2021)

HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic
por: Uusküla, Anneli, et al.
Publicado: (2017)

HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
por: Page, Kimberly, et al.
Publicado: (2019)

Socioeconomic and racial/ethnic spatial polarization and incarceration among people who inject drugs in 19 US metropolitan areas, 2015()
por: Wise, Akilah, et al.
Publicado: (2023)

Adapted “Break the Cycle for Avant Garde” intervention to reduce injection assisting and promoting behaviours in people who inject drugs in Tallinn, Estonia: A pre- post trial
por: Uusküla, Anneli, et al.
Publicado: (2023)

Mental Disorders Are Associated With Leukocytes Telomere Shortening Among People Who Inject Drugs
por: Durand, Mélusine, et al.
Publicado: (2022)

The opioid epidemic and endocarditis: Frontiers in the management of injection drug use–related endocarditis
por: Mori, Makoto, et al.
Publicado: (2021)

Geographical and temporal variation of injection drug users in Pakistan
por: Archibald, Chris P, et al.
Publicado: (2013)

HCV/HIV coinfection among people who inject drugs and enter opioid substitution treatment in Greece: prevalence and correlates
por: Fotiou, Anastasios, et al.
Publicado: (2016)

Mitochondrial Genotoxicity of Hepatitis C Treatment among People Who Inject Drugs
por: Durand, Mélusine, et al.
Publicado: (2021)

Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users
por: Paraschiv, Simona, et al.
Publicado: (2017)

Acceptability of supervised injection facilities among persons who inject drugs in upstate New York
por: Duncan, Eliana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0fn6bh45k0oftfat79jkin2e4d